| __timestamp | Ligand Pharmaceuticals Incorporated | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 105558000 |
| Thursday, January 1, 2015 | 66107000 | 167094000 |
| Friday, January 1, 2016 | 103402000 | 212608000 |
| Sunday, January 1, 2017 | 135736000 | 285920000 |
| Monday, January 1, 2018 | 245116000 | 322725000 |
| Tuesday, January 1, 2019 | 108935000 | 256174000 |
| Wednesday, January 1, 2020 | 156000000 | 208904000 |
| Friday, January 1, 2021 | 214957000 | 215332000 |
| Saturday, January 1, 2022 | 143418000 | 219525000 |
| Sunday, January 1, 2023 | 96265000 | 266843000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding financial performance is crucial. Over the past decade, Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc. have showcased intriguing trends in their gross profits. From 2014 to 2023, MiMedx consistently outperformed Ligand, with an average gross profit approximately 70% higher. Notably, MiMedx peaked in 2018 with a gross profit of over $320 million, while Ligand's highest was in the same year, reaching around $245 million. However, Ligand's growth trajectory was more volatile, with a significant dip in 2023, dropping to about $96 million. This data highlights the dynamic nature of the pharmaceutical industry, where strategic decisions and market conditions can lead to substantial financial shifts. Investors and analysts should consider these trends when evaluating potential opportunities in the sector.
Gross Profit Trends Compared: Novo Nordisk A/S vs Ligand Pharmaceuticals Incorporated
Who Generates Higher Gross Profit? AstraZeneca PLC or MiMedx Group, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Gross Profit Comparison: Incyte Corporation and Ligand Pharmaceuticals Incorporated Trends
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Catalent, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis
Grifols, S.A. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Alkermes plc vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: MorphoSys AG and MiMedx Group, Inc. Trends
Gross Profit Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc.
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown